The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB
From MaRDI portal
(Redirected from Publication:933282)
Recommendations
- Application of optimal control theory to analysis of cancer chemotherapy regimens
- Optimizing combination therapy in a murine model of HER2+ breast cancer
- Optimal chemotherapy regimens: Influence of tumours on normal cells and several toxicity constraints
- A mathematical model of cancer chemotherapy with an optimal selection of parameters
- Influence of tumours on normal cells and optimal chemotherapy regimens: the case of several drugs and toxicity constraints
Cites work
Cited in
(3)
This page was built for publication: The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q933282)